BROADCASTS.com

b'Jim and Jeff discuss Eli Lilly after the company beat on quarterly profit and hiked its full-year guidance on strong sales of Mounjaro and Zepbound. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market\\u2019s biggest headlines. Signup here: cnbc.com/morningtake \\nCNBC Investing Club Disclaimer'